Diabetic retinopathy is the leading cause of vision loss in working-age adults. Approximately 37.3 million people have diabetes (11.3% of the US population). Diabetic retinopathy is treatable, if detected early. While most diabetic patients may not have an eye care provider, 75% of US adults have a primary care physician.
Fundus imaging that offers simple screening – even with non-ophthalmic personnel.
✓ Autofocus and autoexposure increases ease of use with minimal training required.
✓ New high-contrast optical design for state-of-the-art, digital image capture.
✓ Comprehensive study, 50 degrees field of view.
✓ Cloud connectivity to telemedicine solutions for remote consultations.
Telescreening for diabetic retinopathy in primary care offices increases screening rates by approximately 15% for rural and underserved patients. Our comprehensive diabetic retinopathy screening product portfolio includes everything that is needed in a screening program:
The Aurora pricing makes this portable fundus camera readily accessible in more practice and urgent care environments without requiring an on-premises ophthalmologist for testing or diagnosis. The patient’s test results can be quickly transmitted to a specialist for assessment and provide any needed treatment recommendations.